Lever
Lifestyle
- Regular exercise
- Smoking cessation
- Stress management
Blutwerte · Marker
Oxidiertes LDL
Oxidized LDL · oxLDL · ox-LDL
Lipide & Herz-Kreislauf
- Einheit:
- mg/dL
- Abbreviation
- oxLDL
Oxidized low-density lipoprotein (oxLDL) quantifies the amount of LDL cholesterol that has undergone oxidative modification.
Reference Ranges
Reference
0.5–1.5mg/dL
0.5
1.5
LowNormalHigh
Reference
Unit · mg/dLReference ranges are not standardized and may vary by laboratory. Fasting status may affect results.
Overview
Übersicht
Oxidized low-density lipoprotein (oxLDL) is a modified form of LDL cholesterol that has undergone oxidative modification. It is a key player in the pathogenesis of atherosclerosis, as it promotes inflammation and lipid accumulation in arterial walls, leading to plaque formation. Researchers have observed that oxLDL is internalized by macrophages, contributing to foam cell formation and plaque instability. Clinically, elevated oxLDL levels are associated with increased risk of cardiovascular diseases (CVD) such as coronary artery disease, acute coronary syndromes, and ischemic stroke. It serves as a biomarker for assessing the risk of these conditions, especially in individuals who may not present with traditional risk factors. In the context of athletic performance and biohacking, oxLDL is of interest due to its role in systemic inflammation and potential impact on cardiovascular health and longevity. Monitoring oxLDL levels can provide insights into cardiovascular risk management and the effectiveness of lifestyle interventions. However, several caveats exist, including potential confounders such as diet, oxidative stress, and genetic factors. The measurement of oxLDL may also be influenced by time of day and fasting status, although specific guidelines are not well established. Researchers found that while oxLDL is a promising biomarker, its clinical utility is limited by the lack of standardized assays for routine practice.
Klinische Bedeutung
Elevated oxLDL levels indicate increased oxidative stress and are associated with a higher risk of atherosclerosis and cardiovascular diseases. Low levels may suggest reduced oxidative stress and lower cardiovascular risk.
Dynamics
Trend Interpretation
Rising Values
Progressively rising oxLDL levels suggest increasing cardiovascular risk and may warrant lifestyle or therapeutic interventions. Re-test in 3-6 months.
Falling Values
Decreasing oxLDL levels may indicate improved cardiovascular health or effective intervention.
Re-test Interval
6 months if outside optimal range
Etiology
Causes — High & Low
Cause
Elevated Levels
- High-fat diet
- Smoking
- Chronic inflammation
- Metabolic syndrome
- Diabetes mellitus
Cause
Low Levels
- Low oxidative stress
- Effective antioxidant therapy
- Healthy diet
- Regular physical activity
Protocol
How to Optimize
Lever
Nutrition
- Increase intake of antioxidants
- Consume omega-3 fatty acids
- Reduce saturated fat intake
Lever
Supplementation
- Vitamin E
- Coenzyme Q10
- Omega-3 supplements
Note:
Consult a healthcare provider before starting new supplements, especially if on medication.
Testing Guidelines
✓Fasting Not Required
✓Not Time-Sensitive
Testing Frequency
Annually for individuals at risk of CVD, more frequently if monitoring treatment efficacy.
Interfering Factors
- Recent high-fat meal
- Acute illness
- Oxidative stress from intense exercise
Related Peptides & Hormones
Il 1beta
hormone or peptideCorrelated with
Open Research Questions
Current research suggests that reference ranges for oxidized LDL (oxLDL) and its role as a reliable prognostic biomarker in various cardiovascular diseases remain debated. Researchers have not yet established optimal targets for oxLDL levels or fully elucidated confounding factors such as genetic polymorphisms and comorbid conditions. Additionally, clinical questions regarding the predictive value of oxLDL in specific populations, such as those with psoriasis or acute coronary syndrome, remain unanswered.
52 Research Publications
2,180
Total Citations
16
Human/RCT
4.6
Avg. Influence
2025
Latest
Sort
Filter
01Top
#01
Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older Adults.
HumanInfluence11.0
383
This study evaluated the effects of the mitochondrial antioxidant MitoQ on vascular function in older adults. Researchers observed that MitoQ supplementation improved endothelial function and reduced plasma levels of oxidized low-density lipoprotein (oxLDL). The findings suggest MitoQ's potential in enhancing vascular health in aging populations.
02Top
#02
Scavenger receptors, oxidized LDL, and atherosclerosis.
In VitroInfluence13.0
347
This study explored the binding of oxidized LDL (oxLDL) to scavenger receptors in macrophages. Researchers found that oxidized phospholipids in oxLDL play a significant role in its uptake by macrophages, which is crucial for understanding atherogenesis. The study suggests that the persistence of receptors for oxLDL is linked to their role in recognizing damaged cells.
03Top
#03
Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.
ReviewInfluence13.0
324
This review explored oxidized low-density lipoprotein (OxLDL) as a biomarker for cardiovascular diseases. Researchers found that elevated OxLDL levels are associated with all stages of atherosclerosis and related conditions such as diabetes and obesity. The study highlighted the need for further validation of OxLDL assays for clinical use.
04
#04
Oxidation of LDL and its clinical implication.
ReviewInfluence6.0
229
Researchers reviewed the clinical implications of oxidized LDL (oxLDL) in atherosclerosis, finding that oxLDL promotes inflammatory responses and foam cell formation. They noted that autoantibodies against oxLDL complexes may be linked to arterial thrombosis, highlighting the complex role of oxLDL in cardiovascular disease.
05
#05
Oxidized LDL and NO synthesis--Biomarkers of endothelial dysfunction and ageing.
Gradinaru Daniela, et al. · Mechanisms of ageing and development · 2015
ReviewInfluence6.0
160
This review explored the relationship between oxidized LDL (oxLDL) and nitric oxide (NO) in vascular health, suggesting both as biomarkers of endothelial dysfunction and aging. Researchers highlighted the impact of metabolic status on LDL oxidation and NO synthesis, indicating their relevance in cardiovascular disease prevention and diagnosis.
Key findings
- 01Researchers observed that metabolic health affects the levels of oxidized LDL and nitric oxide, which are linked to oxidative stress.
- 02The study indicates that oxidized LDL and nitric oxide can be used as biomarkers to predict cardiovascular outcomes in humans.
- 03Evidence suggests that these biomarkers are significant in understanding vascular aging and related diseases.
06
#06
Challenges and advances in the management of inflammation in atherosclerosis.
Review
133
This review examined the role of inflammation in atherosclerosis, highlighting how immune cells like macrophages and T cells contribute to disease progression. Researchers found that oxidized low-density lipoprotein (oxLDL) is ingested by macrophages, leading to plaque formation and instability. The study also discussed advancements in imaging and biomarker technologies that enhance understanding of atherosclerosis.
07
#07
Role of myeloperoxidase in inflammation and atherosclerosis (Review).
ReviewInfluence2.0
98
This review examined the role of myeloperoxidase (MPO) in atherosclerosis. Researchers found that MPO contributes to LDL oxidation and is present in atherosclerotic lesions, linking high MPO levels to an increased risk of coronary artery disease. The study highlighted the need for further research on MPO's role in cardiovascular diseases.
08
#08
Oxidative stress and organ damages.
Review
94
This review focused on oxidative stress and its role in various diseases, including cardiovascular conditions. Researchers found that oxidized LDL is a significant factor in organ damage related to oxidative stress. The study suggests measuring oxidative stress status as a potential biomarker for disease states.
09
#09
Mitochondrial function and oxidative stress markers in higher-frequency episodic migraine.
In VitroInfluence4.0
65
This study explored mitochondrial function and oxidative stress markers in patients with higher-frequency episodic migraine. Researchers found that oxidized LDL levels were normal in most patients, while other oxidative stress markers were abnormal. The study indicates a potential link between oxidative stress and migraine pathophysiology.
10
#10
LOX-1 in atherosclerotic disease.
HumanInfluence1.0
49
This study investigated the role of LOX-1 in atherosclerosis and its association with cardiovascular risk factors. Researchers found that serum levels of LOX-1 ligands were linked to carotid intima-media thickness and the incidence of coronary artery disease. The study suggested that soluble LOX-1 could be a better biomarker for early diagnosis of acute coronary syndrome.
Publication Trend
Research publications about Oxidiertes LDL over time
10totalTrack your bloodwork in PepStack
Log lab results, track trends and optimize your biomarkers over time.
Legal Disclaimer
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer